Health information technology company QuadraMed Corp., Reston, Va., has completed its
previously announced sale to Francisco Partners, a private-equity firm focused on technology. The agreement's terms indicate that QuadraMed's common stockholders are entitled to receive $8.50 in cash, without interest, minus any applicable withholding taxes, for each share of common stock they own, while the company's Series A preferred stockholders are entitled to receive $13.71, without any interest, for each Series A preferred stock they own, other than dissenting shares.
QuadraMed has clients at more than 2,000 healthcare facilities. Francisco Partners has about $5 billion in capital and has offices in both San Francisco and London.
